Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1, 2 Study of Mesenchymal Stem Cells Injection in ALS (Amyotrophic Lateral Sclerosis) Patients

NCT02116634 is registered in ClinicalTrials.gov with Alzahra Hospital, Iran as lead sponsor.

NCT NCT02116634
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02116634 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1, 2 Study of Mesenchymal Stem Cells Injection in ALS (Amyotrophic Lateral Sclerosis) Patients
Lead sponsor
Alzahra Hospital, Iran
Phase
Phase 1/2
Overall status
Withdrawn
Start date
May 31, 2015
Completion date
May 31, 2017
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyotrophic lateral sclerosis